High-Flow Nasal Cannula Therapy Versus Intermittent Noninvasive Ventilation in Obese Subjects After Cardiothoracic Surgery.

BACKGROUND: Obese patients are considered at risk of respiratory failure after cardiothoracic surgery. High-flow nasal cannula has demonstrated its non-inferiority after cardiothoracic surgery compared to noninvasive ventilation (NIV), which is the recommended treatment in obese patients. We hypothe...

Descripción completa

Detalles Bibliográficos
Publicado en:Respiratory Care Vol. 62; no. 9; pp. 1193 - 1203
Autores principales: Stéphan, François, Bérard, Laurence, Rézaiguia-Delclaux, Saida, Amaru, Priscilla
Formato: research tables/charts randomized controlled trial Journal Article
Publicado: Mary Ann Liebert, Inc. Sep2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=124860247&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 124860247
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00201324
        4GG
      jtl: Respiratory Care
      issn: 00201324
      maglogo: N
    pubinfo:
      dt: Sep2017
      vid: 62
      iid: 9
      pid: 1365
      pub: Mary Ann Liebert, Inc.
      place: New Rochelle, New York
    artinfo:
      ui:
        124860247
        124860247
        124860247
        10.4187/respcare.05473
        124860247
      ppf: 1193
      ppct: 10
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: High-Flow Nasal Cannula Therapy Versus Intermittent Noninvasive Ventilation in Obese Subjects After Cardiothoracic Surgery.
      aug:
        au:
          Stéphan, François
          Bérard, Laurence
          Rézaiguia-Delclaux, Saida
          Amaru, Priscilla
        affil: Service de Réanimation adulte, Hôpital Marie Lannelongue, Le Plessis Robinson, France
      sug:
        subj:
          Nasal Cannula
          Obesity Therapy
          Ventilation
          Cardiac Surgery
          Human
          Noninvasive Procedures
          Respiratory Failure Risk Factors
          Post Hoc Analysis
          Data Analysis Software
          Randomized Controlled Trials
          Confidence Intervals
          Treatment Failure Evaluation
          Intubation, Intratracheal
          Continuous Positive Airway Pressure
          Chi Square Test
          Fisher's Exact Test
          Middle Age
          Body Mass Index Evaluation
          Male
          Female
          Infection Risk Factors
          Middle Aged: 45-64 years
          Male
          Female
      ab: BACKGROUND: Obese patients are considered at risk of respiratory failure after cardiothoracic surgery. High-flow nasal cannula has demonstrated its non-inferiority after cardiothoracic surgery compared to noninvasive ventilation (NIV), which is the recommended treatment in obese patients. We hypothesized that NIV was superior to high-flow nasal cannula for preventing or resolving acute respiratory failure after cardiothoracic surgery in this population. METHODS: We performed a post hoc analysis of a randomized, controlled trial. Obese subjects were randomly assigned to receive NIV for at least 4 h/d (inspiratory pressure, 8 cm H2O; expiratory pressure, 4 cm H2O; FIO2, 0.5) or high-flow nasal cannula delivered continuously (flow, 50 L/min, FIO2 0.5). RESULTS: Treatment failure (defined as re-intubation, switch to the other treatment, or premature discontinuation) occurred in 21 of 136 (15.4%, 95% CI 9.8-22.6%) subjects with NIV compared to 18 of 135 (13.3%, 95% CI 8.1-20.3%) subjects with high-flow nasal cannula (P = .62). No significant differences were found for dyspnea and comfort scores. Skin breakdown was significantly more common with NIV after 24 h (9.2%, 95% CI 5.0-16.0 vs 1.6%, 95% CI 1.0-6.0; P = .01). No significant differences were found for ICU mortality (5.9% for subjects with NIV vs 2.2% for subjects with high-flow nasal cannula, P = .22) or for any of the other secondary outcomes. CONCLUSIONS: Among obese cardiothoracic surgery subjects with or without respiratory failure, the use of continuous high-flow nasal cannula compared to intermittent NIV (8/4 cm H2O) did not result in a worse rate of treatment failure. Because high-flow nasal cannula presents some advantages, it may be used instead of NIV in obese patients after cardiothoracic surgery.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        randomized controlled trial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N